The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (2 analysts) rates it none, with a mean price target of $136.
BAE Systems plc
BAESY · PNK · USD · Market cap $81.2B · 111,400 employees
BAE Systems plc provides defense, aerospace, and security solutions in the United States, the United Kingdom, the Middle East, Australia, Kingdom of Saudi Arabia, Europe, and internationally.
FAIL · Does not pass the screenPrice as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 18:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price106.37 USD at the 4 Nov 2026 close
- Our value readFair vs our fair value, as of 4 Nov 2026
- Our regime readMarkup, as of 4 Nov 2026
- Ethical screenDoes not pass
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $101.70 to $134.31, base estimate $116.80 (screen dated 2026-11-04).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
BAE Systems plc holds its Markup at $106.37. The statistical read favours the buyers, held for 4 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 4 days |
| Price at the screen | $106.37 |
| Valuation | 29.60 trailing · 20.74 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | -0.04 |
Five Screens, Shown in Full
Does not pass. Business activity
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited sector: defense | Fail |
| Debt load | 0.00% | Below 33% | Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.48% | Below 5% | Only 0.5% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
BAE Systems does not clear the screen at the business-activity stage. It operates in aerospace and defense, so the financial ratios are not the deciding factor here.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BAESY's ethical verdict changes
Today BAESY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate / American Friends Service Committee / Don’t Buy Into Occupation / Palestinian BDS National Committee — category: Corporate Complicity Report / Annex 2 Company List. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades at roughly a 5% discount to our $116.80 fair value, moderate competitive moat, 7.70% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 8.9% discount to the base estimate.
Third-party analyst targets: 3 covering, consensus Buy. The average target sits +19% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $116.80, with a range of $101.70 to $134.31, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsDefense spending meets an ethical hard stop
Governments keep signing bigger cheques for jets and radar, yet the cash never quite reaches the same moral ledger as civilian tech. BAE Systems sits at the centre of that flow, posting 7% revenue growth, a 7% profit margin and 18% ROE while trading on 19.2 times forward earnings. The numbers look steady and the 19% gap to our fair value hints at value, but none of it clears the first gate.
We pass outright. The ethical screen flags core business activity in weapons and defence platforms, and that single failure overrides every multiple and growth line. Moderate moat or not, two analysts and a $136 median target cannot shift the line we draw.
The real exposure sits in long contract cycles and shifting government budgets that can flatten earnings without warning. Currency moves across its US, UK and Middle East footprint add another layer that rarely appears in the headline margin. Analysis, not advice.
| Forward P/E | 20.7xexpensive even after accounting for its growth |
| Trailing P/E | 29.6xa premium valuation |
| EPS, trailing | 3.75 |
| EPS, forward | 5.35 |
| Revenue growth | +7.7%slow but positive growth |
| Profit margin | 7.2%thin but positive margins |
| Return on equity | 18.6%a solid return on shareholder capital |
| FCF yield | 3.62% |
| Dividend yield | 190.00% |
| Debt to equity | 0.73moderate, manageable leverage |
| Current ratio | 1.02adequate liquidity, worth monitoring |
| Beta | -0.04barely tracks the market's swings |
| 52-week range | 84.50 - 126.00 |
| Moat | MODERATE |
| Market cap | $81.2B |
| Employees | 111,400 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBAESY trades on PNK (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (2 analysts) rates it none, with a mean price target of $136.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (2 analysts) rates it none, with a mean price target of $136.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (2 analysts) rates it none, with a mean price target of $136.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (2 analysts) rates it none, with a mean price target of $136.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 15.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (2 analysts) rates it none, with a mean price target of $136.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (2 analysts) rates it none, with a mean price target of $136.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (2 analysts) rates it none, with a mean price target of $136.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Space on-Board Computing Platforms - Global Strategic Business Report 2026 | Capitalize on the $4.2B Market by 2032; Outmaneuver Airbus, SpaceX, BAE Systems and Lockheed Martin Yahoo Finance · 1d ago
- European defense stocks slip as Democratic midterm win raises spending worries Yahoo Finance · 1d ago
- Precious metals rally propels miners to top of FTSE 100 Yahoo Finance · 1d ago
- UK supply chain leaders unite to put SMEs at the heart of defence readiness Yahoo Finance · 1d ago
- Forensic Technologies and Services - Global Strategic Business Report: Secure Share of a $44.7B Market by 2030 as Thermo Fisher, Illumina, Agilent and BAE Systems Accelerate AI-Led Forensics Yahoo Finance · 3d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $104.10 | -0.3% | · | $997 | -0.3% |
| 2 months | $117.88 | -12.0% | $1.22 | $891 | -10.9% |
| 3 months | $121.97 | -14.9% | $1.22 | $861 | -13.9% |
| 6 months | $90.34 | +14.9% | $1.22 | $1,162 | +16.2% |
| 1 year | $98.53 | +5.3% | $1.94 | $1,073 | +7.3% |
| 2 years | $69.23 | +49.9% | $3.65 | $1,551 | +55.1% |
| 3 years | $45.18 | +129.7% | $5.16 | $2,411 | +141.1% |
| 5 years | $26.89 | +285.8% | $7.80 | $4,148 | +314.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BAESY does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.